NL300201I1 - Samenstellingen en formuleringen voor het produceren van analgesie en voor het remmen van de progressie van neuropathische pijn. - Google Patents

Samenstellingen en formuleringen voor het produceren van analgesie en voor het remmen van de progressie van neuropathische pijn.

Info

Publication number
NL300201I1
NL300201I1 NL300201C NL300201C NL300201I1 NL 300201 I1 NL300201 I1 NL 300201I1 NL 300201 C NL300201 C NL 300201C NL 300201 C NL300201 C NL 300201C NL 300201 I1 NL300201 I1 NL 300201I1
Authority
NL
Netherlands
Prior art keywords
progression
inhibiting
neuropathic pain
formulations
compositions
Prior art date
Application number
NL300201C
Other languages
English (en)
Other versions
NL300201I2 (nl
Original Assignee
Elan Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/496,847 external-priority patent/US5795864A/en
Priority claimed from US08/613,400 external-priority patent/US6054429A/en
Application filed by Elan Pharm Inc filed Critical Elan Pharm Inc
Publication of NL300201I1 publication Critical patent/NL300201I1/nl
Publication of NL300201I2 publication Critical patent/NL300201I2/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Control Of El Displays (AREA)
  • Saccharide Compounds (AREA)
NL300201C 1995-06-27 2005-07-13 Samenstellingen en formuleringen voor het produceren van analgesie NL300201I2 (nl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/496,847 US5795864A (en) 1995-06-27 1995-06-27 Stable omega conopetide formulations
US08/613,400 US6054429A (en) 1996-03-08 1996-03-08 Epidural method of producing analgesia
PCT/US1996/011041 WO1997001351A1 (en) 1995-06-27 1996-06-26 Compositions and formulations for producing analgesia and for inhibiting progression of neuropathic pain disorders

Publications (2)

Publication Number Publication Date
NL300201I1 true NL300201I1 (nl) 2005-09-01
NL300201I2 NL300201I2 (nl) 2006-02-01

Family

ID=27052304

Family Applications (1)

Application Number Title Priority Date Filing Date
NL300201C NL300201I2 (nl) 1995-06-27 2005-07-13 Samenstellingen en formuleringen voor het produceren van analgesie

Country Status (14)

Country Link
EP (2) EP1336409B1 (nl)
JP (1) JP2838073B2 (nl)
AT (2) ATE359086T1 (nl)
AU (1) AU695166B2 (nl)
CA (1) CA2224795C (nl)
DE (3) DE69637021T2 (nl)
DK (2) DK0835126T3 (nl)
ES (2) ES2194998T3 (nl)
FR (1) FR05C0027I2 (nl)
HK (1) HK1058146A1 (nl)
LU (1) LU91181I2 (nl)
NL (1) NL300201I2 (nl)
PT (2) PT835126E (nl)
WO (1) WO1997001351A1 (nl)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5931809A (en) 1995-07-14 1999-08-03 Depotech Corporation Epidural administration of therapeutic compounds with sustained rate of release
EP1054896A1 (en) * 1998-02-20 2000-11-29 Zeneca Limited ANALGESIC PEPTIDES FROM VENOM OF $i(GRAMMOSTOLA SPATULATA) AND USE THEREOF
AUPP627498A0 (en) 1998-10-02 1998-10-22 University Of Queensland, The Novel peptides - i
PT1572725E (pt) 2002-12-02 2012-05-28 Xenome Ltd Péptidos de qui-conotoxina possuindo um ácido piroglutâmico n-terminal
EP2386566A3 (en) 2002-12-02 2012-02-15 Xenome Ltd Chi-conotoxin peptides (II)
ATE365174T1 (de) 2003-01-28 2007-07-15 Microbia Inc Zusammensetzungen zur behandlung von gastrointestinalen störungen
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
CA2930900C (en) 2003-10-02 2018-10-16 Jazz Pharmaceuticals International Limited Combinations of ziconotide and opioids for reducing pain
GB0410215D0 (en) * 2004-05-07 2004-06-09 Lescroart Pol Nerve damage
US8188048B2 (en) 2006-06-23 2012-05-29 Xenome Limited Combination therapy
JP2010509209A (ja) * 2006-11-04 2010-03-25 エニジェン カンパニー リミテッド 新規なω−コノトキシン
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
MX354786B (es) 2007-06-04 2018-03-21 Synergy Pharmaceuticals Inc Agonistas de guanilato ciclasa utiles para el tratamiento de trastornos gastrointestinales, inflamacion, cancer y otros trastornos.
US20110129508A1 (en) * 2008-05-06 2011-06-02 Relevare Aust. Pty Ltd Methods and compositions for the management of pain using omega-conotoxins
JP2011522828A (ja) 2008-06-04 2011-08-04 シナジー ファーマシューティカルズ インコーポレイテッド 胃腸障害、炎症、癌、およびその他の障害の治療のために有用なグアニル酸シクラーゼのアゴニスト
EP3241839B1 (en) 2008-07-16 2019-09-04 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
WO2010065751A2 (en) 2008-12-03 2010-06-10 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase c agonists and methods of use
KR101766619B1 (ko) 2008-12-31 2017-08-08 알데릭스, 인코포레이티드 체액 저류 또는 염 과부하와 연관된 장애 및 위장관 장애의 치료 시에 ｎｈｅ-매개된 역수송을 억제하는 화합물 및 방법
WO2018129556A1 (en) 2017-01-09 2018-07-12 Ardelyx, Inc. Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
US10376481B2 (en) 2012-08-21 2019-08-13 Ardelyx, Inc. Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
CN104902930A (zh) 2012-08-21 2015-09-09 阿德利克斯公司 在治疗与液体潴留或盐分过载相关的疾病和胃肠道疾病中用于抑制nhe-介导的反向转运的化合物和方法
WO2014151206A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
US9486494B2 (en) 2013-03-15 2016-11-08 Synergy Pharmaceuticals, Inc. Compositions useful for the treatment of gastrointestinal disorders
PT2983667T (pt) 2013-04-12 2019-07-11 Ardelyx Inc Compostos e métodos de ligação ao nhe3 para inibir o transporte de fosfato
EA201592263A1 (ru) 2013-06-05 2016-05-31 Синерджи Фармасьютикалз, Инк. Ультрачистые агонисты гуанилатциклазы c, способ их получения и использования
CA3049678A1 (en) 2017-01-09 2018-07-12 Ardelyx, Inc. Compounds useful for treating gastrointestinal tract disorders
MA47203A (fr) 2017-01-09 2019-11-13 Ardelyx Inc Inhibiteurs d'antiport à médiation par nhe

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3926287A1 (de) * 1989-08-09 1991-02-21 Bernhard Clasbrummel Medizinische anwendung von omega-conotoxin gvia oder omega-conotoxin gvia-analoga zur sympathikolyse
US5051403A (en) * 1989-11-22 1991-09-24 Neurex Corporation Method of treating ischemia-related neuronal damage
AU3074592A (en) * 1991-11-12 1993-06-15 Neurex Corporation Compositions for delayed treatment of ischemia-related neuronal damage
CA2151741C (en) * 1991-12-30 2001-12-11 Alan Justice Methods of producing analgesia and enhancing opiate analgesia
JPH06247879A (ja) * 1993-02-17 1994-09-06 Bristol Myers Squibb Co デオキシチミジンヌクレオシドを含有する注射用製剤の安定化方法およびその方法によって得られる安定化注射用製剤

Also Published As

Publication number Publication date
EP1336409A1 (en) 2003-08-20
FR05C0027I1 (nl) 2005-08-12
ES2194998T3 (es) 2003-12-01
DE122005000043I2 (de) 2006-08-03
DE69637021D1 (de) 2007-05-24
PT1336409E (pt) 2007-06-29
DE69627153D1 (de) 2003-05-08
HK1058146A1 (en) 2004-05-07
ES2283671T3 (es) 2007-11-01
DE69627153T2 (de) 2003-12-04
DK1336409T3 (da) 2007-08-13
ATE359086T1 (de) 2007-05-15
FR05C0027I2 (nl) 2006-12-29
PT835126E (pt) 2003-07-31
CA2224795A1 (en) 1997-01-16
DK0835126T3 (da) 2003-07-14
WO1997001351A1 (en) 1997-01-16
DE69637021T2 (de) 2008-01-10
CA2224795C (en) 2001-04-03
AU695166B2 (en) 1998-08-06
JP2838073B2 (ja) 1998-12-16
AU6400296A (en) 1997-01-30
EP0835126B1 (en) 2003-04-02
EP0835126A1 (en) 1998-04-15
EP1336409B1 (en) 2007-04-11
JPH09104634A (ja) 1997-04-22
NL300201I2 (nl) 2006-02-01
DE122005000043I1 (de) 2006-06-29
LU91181I2 (fr) 2005-09-06
ATE235914T1 (de) 2003-04-15

Similar Documents

Publication Publication Date Title
NL300201I1 (nl) Samenstellingen en formuleringen voor het produceren van analgesie en voor het remmen van de progressie van neuropathische pijn.
IL121170A0 (en) Compositions for the treatment of dermatological disorders
NL1003813A1 (nl) Inrichting voor de behandeling van luchtwegobstructies.
GB2272646B (en) Instrument for registration of the dental bite
HUP9901707A3 (en) Pharmaceutical and diet formulations for the prophylaxis and treatment of gastrointestinal disorders
HUP9802634A3 (en) Use of benzimidazoles for the manufacture of pharmaceutical compositions for the treatment of leukemia
HUP0004331A3 (en) Use of phanquinone for producing pharmaceutical compositions for the treatment of alzheimer's disease and combined pharmaceutical compositions containing it
HUP9900924A3 (en) Substituted 1 betha-d-arabinofuranosylcytosine derivatives and use of the same for producing pharmaceutical compositions having antitumor activity
AU5053296A (en) Pharmaceutical agents for the treatment of Alzheimer's disease
ZA961897B (en) 6,7-substituted-2-aminotetralines and use thereof
HUP0000570A3 (en) Use of 17 alpha-dihydroequilenin for producing pharmaceutical compositions for the treatment of free radical induced disease states
AU6955294A (en) Agents for the prevention and treatment of parkinson's disease
HUP0001499A3 (en) Use of 7alpha-methyl-17alpha-ethynyl-estrane derivative for producing pharmaceutical compositions for the treatment of atherosclerosis
HUP0000476A3 (en) Use of 17 betha-dihydroequilenin for producing pharmaceutical compositions for the treatment of free radical induced disease states
ZA925983B (en) Pharmaceutical compositions for the treatment of skin disorders
IL116548A0 (en) Pharmaceutical compositions for treatment of the eyes
AU2002300055A1 (en) Highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of alzheimer's disease and dementias
ITTO920519A0 (it) Sussidio terapeuticodinamico per larieducazione sensitivo-motoria del-l'arto superiore in pazienti cerebrolesi.
IT225039Z2 (it) Manipolo per sollecitazioni elettrostatiche dell'epidermide
KR970011708U (ko) 제품의 높이조절장치
AU7699496A (en) Use of 2-iminobenzothiazolines for treating parkinson's disease and parkinsonian syndromes
NO984964D0 (no) Anvendelse av fosfonsyreestere for behandling av funksjonelle forstyrrelser i hjernen og depresjon
IT1295003B1 (it) Composizioni farmaceutiche per il trattamento dell'herpes simplex
KR970015598U (ko) 텔레비전의 온타이머기능 제어장치